Page last updated: 2024-10-18

dihydroxyphenylalanine and Ovarian Neoplasms

dihydroxyphenylalanine has been researched along with Ovarian Neoplasms in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martiniova, L2
Lai, EW2
Thomasson, D2
Kiesewetter, DO2
Seidel, J2
Merino, MJ1
Kvetnansky, R2
Pacak, K2
Cleary, S1
Dawson, LF1
Phillips, JK1
Chen, X1
Eisenhofer, G1
Powers, JF1

Other Studies

2 other studies available for dihydroxyphenylalanine and Ovarian Neoplasms

ArticleYear
Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.
    Endocrine regulations, 2009, Volume: 43, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female;

2009
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Female; Liver Ne

2012